MCL1 and breast carcinoma: Addressing this key point, we set out to determine whether fully established tumours in an immune competent breast cancer model were dependent on MCL-1 and, if so, whether this was due to anti-apoptotic MCL-1 activity and/or its non-apoptotic functions.